Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial

The global distribution and burden of dengue

Samir Bhatt, Peter W. Gething, Oliver J. Brady et al. · Nature · 2013 · 10.2K citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +12

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

Arunee Sabchareon, Derek Wallace, Chukiat Sirivichayakul et al. · The Lancet · 2012 · 814 citations

Veterinary Medicine, Child Health, Infectious Diseases +17

High Circulating Levels of the Dengue Virus Nonstructural Protein NS1 Early in Dengue Illness Correlate with the Development of Dengue Hemorrhagic Fever

Daniel H. Libraty, Paul R. Young, Darren Pickering et al. · The Journal of Infectious Diseases · 2002 · 737 citations

Veterinary Medicine, Infectious Diseases, Pathobiology +11

Enzyme-Linked Immunosorbent Assay Specific to Dengue Virus Type 1 Nonstructural Protein NS1 Reveals Circulation of the Antigen in the Blood during the Acute Phase of Disease in Patients Experiencing Primary or Secondary Infections

Sophie Alcon, Antoine Talarmin, Monique Debruyne et al. · Journal of Clinical Microbiology · 2002 · 680 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Biology +13

Evidence That Maternal Dengue Antibodies Are Important in the Development of Dengue Hemorrhagic Fever in Infants

Srisakul Kliks, Suchitra Nimmanitya, Ananda Nisalak et al. · American Journal of Tropical Medicine and Hygiene · 1988 · 585 citations

Medicine, Immunology, Pediatrics +13